Modeling the regulatory mechanisms by which NLRX1 modulates innate immune responses to Helicobacter pylori infection

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Philipson, Casandra W ^a   Bassaganya Riera, Josep ^a,b   Viladomiu, Monica ^a   Kronsteiner, Barbara ^a   Abedi, Vida ^a   Hoops, Stefan ^a   Michalak, Pawel ^a   Kang, Lin ^a   Girardin, Stephen E ^c   Hontecillas, Raquel ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NUCLEOTIDE BINDING DOMAIN AND LEUCINE RICH REPEAT CONTAINING PROTEIN X1; PATTERN RECOGNITION RECEPTOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG; MITOCHONDRIAL PROTEIN; NLRX1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; DOWN REGULATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MATHEMATICAL MODEL; MOLECULAR INTERACTION; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN EXPRESSION; RNA SEQUENCE; TIME SERIES ANALYSIS; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; COMPUTER SIMULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; MICROBIOLOGY; MUTANT MOUSE STRAIN; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; COMPUTER SIMULATION; FEMALE; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL;

EID: 84947416904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137839     Document Type: Article

References (85)

1. Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013; 11(6):385-99. Epub 2013/05/09. doi: 10.1038/nrmicro3016 nrmicro3016 [pii].PMID: 23652324; PubMed Central PMCID: PMC3733401.
2. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology. 2008; 134(1):306-23. Epub 2008/01/02. doi: 10.1053/j.gastro.2007.11.009 S0016-5085(07)02016-1 [pii].PMID: 18166359.
3. Muller A, Oertli M, Arnold IC. H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection. Cell communication and signaling: CCS. 2011; 9(1):25. doi: 10.1186/1478-811X-9-25 PMID: 22044597; PubMed Central PMCID: PMC3214186.
4. Sayi A, Kohler E, Toller IM, Flavell RA, Muller W, Roers A, et al. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. Journal of immunology. 2011; 186(2):878-90. doi: 10.4049/jimmunol.1002269 PMID: 21149607.
5. Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, Matsumoto Y, et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest. 2010; 120(5):1645-62. Epub 2010/04/15. 39481 [pii] doi: 10.1172/JCI39481 PMID: 20389019; PubMed Central PMCID: PMC2860924.
6. Kronsteiner B, Bassaganya-Riera J, Philipson N, Hontecillas R. Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infection. Gut microbes. 2014; 5(3):357-62. doi: 10.4161/gmic.28899 PMID: 24755940; PubMed Central PMCID: PMC4153774.
7. Kronsteiner B, Bassaganya-Riera J, Philipson C, Viladomiu M, Carbo A, Pedragosa M, et al. Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses. Infect Immun. 2013; 81(10):3803-13. Epub 2013/07/31. doi: 10.1128/IAI.00660-13 IAI.00660-13 [pii].PMID: 23897614; PubMed Central PMCID: PMC3811743.
8. Carbo A, Bassaganya-Riera J, Pedragosa M, Viladomiu M, Marathe M, Eubank S, et al. Predictive computational modeling of the mucosal immune responses during Helicobacter pylori infection. PLoS One. 2013; 8(9):e73365. Epub 2013/09/17. doi: 10.1371/journal.pone.0073365 PONE-D-13-23357 [pii].PMID: 24039925; PubMed Central PMCID: PMC3764126.
9. Carbo A, Olivares-Villagomez D, Hontecillas R, Bassaganya-Riera J, Chaturvedi R, Piazuelo MB, et al. Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection. MBio. 2014; 5(4):e01243-14. Epub 2014/07/24. doi: 10.1128/mBio.01243-14 e01243-14 [pii] mBio.01243-14 [pii].PMID: 25053783; PubMed Central PMCID: PMC4120195.
10. Wendelsdorf KV, Alam M, Bassaganya-Riera J, Bisset K, Eubank S, Hontecillas R, et al. ENteric Immunity SImulator: a tool for in silico study of gastroenteric infections. IEEE transactions on nanobioscience. 2012; 11(3):273-88. doi: 10.1109/TNB.2012.2211891 PMID: 22987134; PubMed Central PMCID: PMC3715318.
11. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics. 2000; 25(1):25-9. doi: 10.1038/75556 PMID: 10802651; PubMed Central PMCID: PMC3037419.
12. Gene Ontology C. Gene Ontology Consortium: going forward. Nucleic acids research. 2015; 43(Database issue):D1049-56. doi: 10.1093/nar/gku1179 PMID: 25428369; PubMed Central PMCID: PMC4383973.
13. Qiao S, Dennis M, Song X, Vadysirisack DD, Salunke D, Nash Z, et al. A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity. Nature communications. 2015; 6:7014. doi: 10.1038/ncomms8014 PMID: 25916556; PubMed Central PMCID: PMC4421852.
14. Dennis MD, Kimball SR, Fort PE, Jefferson LS. Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents. The Journal of biological chemistry. 2015; 290(6):3865-74. doi: 10.1074/jbc.M114.623058 PMID: 25548280; PubMed Central PMCID: PMC4319049.
15. Dennis MD, Coleman CS, Berg A, Jefferson LS, Kimball SR. REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling. Science signaling. 2014; 7(335): ra68. doi: 10.1126/scisignal.2005103 PMID: 25056877; PubMed Central PMCID: PMC4145530.
16. Rad R, Ballhorn W, Voland P, Eisenacher K, Mages J, Rad L, et al. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology. 2009; 136(7):2247-57. doi: 10.1053/j.gastro.2009.02.066 PMID: 19272387.
17. Mustapha P, Paris I, Garcia M, Tran CT, Cremniter J, Garnier M, et al. Chemokines and antimicrobial peptides have a cag-dependent early response to Helicobacter pylori infection in primary human gastric epithelial cells. Infection and immunity. 2014; 82(7):2881-9. doi: 10.1128/IAI.01517-13 PMID: 24778119; PubMed Central PMCID: PMC4097638.
18. Castano-Rodriguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM. The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses. PLoS One. 2014; 9(6):e98899. Epub 2014/06/06. doi: 10.1371/journal.pone.0098899 PONE-D-14-09605 [pii].PMID: 24901306; PubMed Central PMCID: PMC4047072.
19. Sun X, Zhang M, El-Zataari M, Owyang SY, Eaton KA, Liu M, et al. TLR2 mediates Helicobacter pyloriinduced tolerogenic immune response in mice. PloS one. 2013; 8(9):e74595. doi: 10.1371/journal.pone.0074595 PMID: 24058595; PubMed Central PMCID: PMC3772856.
20. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, et al. Identification of genetic loci associated with Helicobacter pylori serologic status. Jama. 2013; 309(18):1912-20. doi: 10.1001/jama.2013.4350 PMID: 23652523.
21. Kurokawa K, Ryu KH, Ichikawa R, Masuda A, Kim MS, Lee H, et al. Novel bacterial lipoprotein structures conserved in low-GC content gram-positive bacteria are recognized by Toll-like receptor 2. The Journal of biological chemistry. 2012; 287(16):13170-81. doi: 10.1074/jbc.M111.292235 PMID: 22303020; PubMed Central PMCID: PMC3339964.
22. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Tolllike receptor 4 complex. FEMS immunology and medical microbiology. 2007; 51(1):140-8. doi: 10.1111/j.1574-695X.2007.00288.x PMID: 17645528.
23. Castano-Rodriguez N, Kaakoush NO, Mitchell HM. Pattern-recognition receptors and gastric cancer. Frontiers in immunology. 2014; 5:336. doi: 10.3389/fimmu.2014.00336 PMID: 25101079; PubMed Central PMCID: PMC4105827.
24. Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014; 514(7521):187-92. doi: 10.1038/nature13683 PMID: 25119034.
25. Davis BK, Philipson C, Hontecillas R, Eden K, Bassaganya-Riera J, Allen IC. Emerging significance of NLRs in inflammatory bowel disease. Inflammatory bowel diseases. 2014; 20(12):2412-32. doi: 10.1097/MIB.0000000000000151 PMID: 25153506; PubMed Central PMCID: PMC4396872.
26. Kang MJ, Yoon CM, Kim BH, Lee CM, Zhou Y, Sauler M, et al. Suppression of NLRX1 in chronic obstructive pulmonary disease. The Journal of clinical investigation. 2015; 125(6):2458-62. doi: 10.1172/JCI71747 PMID: 25938787.
27. Lord CA, Savitsky D, Sitcheran R, Calame K, Wright JR, Ting JP, et al. Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1. Journal of immunology. 2009; 182 (5):2948-58. doi: 10.4049/jimmunol.0801692 PMID: 19234190; PubMed Central PMCID: PMC2701146.
28. Schneider M, Zimmermann AG, Roberts RA, Zhang L, Swanson KV, Wen H, et al. The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kappaB. Nature immunology. 2012; 13(9):823-31. doi: 10.1038/ni.2378 PMID: 22863753; PubMed Central PMCID: PMC3721195.
29. Ruland J. Return to homeostasis: downregulation of NF-kappaB responses. Nature immunology. 2011; 12(8):709-14. doi: 10.1038/ni.2055 PMID: 21772279.
30. QIAGEN. Ingenuity Pathway Analysis. Available: http://www.ingenuity.com/.
31. Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, et al. COPASI-a COmplex PAthway SImulator. Bioinformatics. 2006; 22(24):3067-74. Epub 2006/10/13. btl485 [pii] doi: 10.1093/bioinformatics/btl485 PMID: 17032683.
32. Mendes P, Hoops S, Sahle S, Gauges R, Dada J, Kummer U. Computational modeling of biochemical networks using COPASI. Methods in molecular biology. 2009; 500:17-59. doi: 10.1007/978-1-59745-525-1-2 PMID: 19399433.
33. Manuzak J, Dillon S, Wilson C. Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria. Clinical and vaccine immunology: CVI. 2012; 19(8):1207-17. doi: 10.1128/CVI.00282-12 PMID: 22695160; PubMed Central PMCID: PMC3416095.
34. Wang YC, Chen CL, Sheu BS, Yang YJ, Tseng PC, Hsieh CY, et al. Helicobacter pylori infection activates Src homology-2 domain-containing phosphatase 2 to suppress IFN-gamma signaling. Journal of immunology. 2014; 193(8):4149-58. doi: 10.4049/jimmunol.1400594 PMID: 25225672.
35. Stolte M. Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet. 1992; 339(8795):745-6. Epub 1992/03/21. PMID: 1347613.
36. Pernitzsch SR, Sharma CM. Transcriptome complexity and riboregulation in the human pathogen Helicobacter pylori. Frontiers in cellular and infection microbiology. 2012; 2:14. Epub 2012/08/25. doi: 10.3389/fcimb.2012.00014 PMID: 22919606; PubMed Central PMCID: PMC3417511.
37. Mane SP, Dominguez-Bello MG, Blaser MJ, Sobral BW, Hontecillas R, Skoneczka J, et al. Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. Journal of bacteriology. 2010; 192(12):3078-92. doi: 10.1128/JB.00063-10 PMID: 20400544; PubMed Central PMCID: PMC2901691.
38. Suerbaum S, Michetti P. Helicobacter pylori infection. The New England journal of medicine. 2002; 347 (15):1175-86. Epub 2002/10/11. doi: 10.1056/NEJMra020542 PMID: 12374879.
39. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. The Journal of clinical investigation. 2004; 113(3):321-33. doi: 10.1172/JCI20925 PMID: 14755326; PubMed Central PMCID: PMC324548.
40. Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila Pa). 2008; 1(5):308-11. Epub 2009/01/14. 1/5/308 [pii] doi: 10.1158/1940-6207.CAPR-08-0170 PMID: 19138974.
41. Vieth M, Masoud B, Meining A, Stolte M. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia? Digestion. 2000; 62(4):225-31. PMID: 11070405.
42. Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Perez-Perez GI, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol. 2000; 95(9):2206-11. PMID: 11007219.
43. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998; 58(4):588-90. PMID: 9485003
44. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology. 2010; 139(6):1894-901 e2; quiz e12. Epub 2010/08/24. S0016-5085 (10)01236-9 [pii] doi: 10.1053/j.gastro.2010.08.018 PMID: 20727889.
45. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut. 2008. PMID: 18194986.
46. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007; 167(8):821-7. PMID: 17452546.
47. Lang L. Childhood acquisition of Helicobacter pylori linked to reduced asthma and allergy risk. Gastroenterology. 2007; 133(1):6. PMID: 17631119.
48. McCune A, Lane A, Murray L, Harvey I, Nair P, Donovan J, et al. Reduced risk of atopic disorders in adults with Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2003; 15(6):637-40. PMID: 12840675.
49. Nanda S. Infection: Helicobacter pylori may protect against IBD-a mechanistic insight. Nat Rev Gastroenterol Hepatol. 2011; 8(6):299. doi: 10.1038/nrgastro.2011.77 PMID: 21643027.
50. Lender N, Talley NJ, Enck P, Haag S, Zipfel S, Morrison M, et al. Review article: associations between Helicobacter pylori and obesity-an ecological study. Aliment Pharmacol Ther. 2014; 40(1):24-31. doi: 10.1111/apt.12790 PMID: 24832176.
51. Bassaganya-Riera J, Dominguez-Bello MG, Kronsteiner B, Carbo A, Lu P, Viladomiu M, et al. Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR gamma-dependent mechanism. PLoS One. 2012; 7(11):e50069. Epub 2012/11/21. doi: 10.1371/journal.pone.0050069 PONE-D-12-10967 [pii].PMID: 23166823; PubMed Central PMCID: PMC3499487.
52. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012; 335 (6071):936-41. doi: 10.1126/science.1214935 PMID: 22363001; PubMed Central PMCID: PMC3564547.
53. Chionh YT, Ng GZ, Ong L, Arulmuruganar A, Stent A, Saeed MA, et al. Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5. Mucosal immunology. 2015; 8(1):68-79. doi: 10.1038/mi.2014.43 PMID: 24866378.
54. Gobert AP, Verriere T, Asim M, Barry DP, Piazuelo MB, de Sablet T, et al. Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori. Journal of immunology. 2014; 193(6):3013-22. doi: 10.4049/jimmunol.1401075 PMID: 25108023; PubMed Central PMCID: PMC4171064.
55. Eftang LL, Esbensen Y, Tannaes TM, Bukholm IR, Bukholm G. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC microbiology. 2012; 12:9. doi: 10.1186/1471-2180-12-9 PMID: 22248188; PubMed Central PMCID: PMC3292955.
56. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. The Journal of experimental medicine. 2000; 191(1):115-28. PMID: 10620610; PubMed Central PMCID: PMC2195807.
57. Chu YT, Wang YH, Wu JJ, Lei HY. Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance. Infection and immunity. 2010; 78(10):4157-65. doi: 10.1128/IAI.00524-10 PMID: 20696835; PubMed Central PMCID: PMC2950335.
58. Wang YH, Wu JJ, Lei HY. The autophagic induction in Helicobacter pylori-infected macrophage. Experimental biology and medicine. 2009; 234(2):171-80. doi: 10.3181/0808-RM-252 PMID: 19064937.
59. Deen NS, Gong L, Naderer T, Devenish RJ, Kwok T. Analysis of the Relative Contribution of Phagocytosis, LC3-Associated Phagocytosis, and Canonical Autophagy During Helicobacter pylori Infection of Macrophages. Helicobacter. 2015. doi: 10.1111/hel.12223 PMID: 25864465.
60. Engler DB, Reuter S, van Wijck Y, Urban S, Kyburz A, Maxeiner J, et al. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(32):11810-5. doi: 10.1073/pnas.1410579111 PMID: 25074917; PubMed Central PMCID: PMC4136625.
61. Hagar JA, Aachoui Y, Miao EA. WildCARDs: inflammatory caspases directly detect LPS. Cell research. 2015; 25(2):149-50. doi: 10.1038/cr.2014.128 PMID: 25267404.
62. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. The Journal of infectious diseases. 2004; 189(10):1914-20. doi: 10.1086/386289 PMID: 15122529.
63. Cullen TW, Giles DK, Wolf LN, Ecobichon C, Boneca IG, Trent MS. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS pathogens. 2011; 7(12):e1002454. doi: 10.1371/journal.ppat.1002454 PMID: 22216004; PubMed Central PMCID: PMC3245313.
64. Kumar Pachathundikandi S, Brandt S, Madassery J, Backert S. Induction of TLR-2 and TLR-5 expression by Helicobacter pylori switches cagPAI-dependent signalling leading to the secretion of IL-8 and TNF-alpha. PLoS One. 2011; 6(5):e19614. Epub 2011/05/17. doi: 10.1371/journal.pone.0019614 PONE-D-10-06232 [pii].PMID: 21573018; PubMed Central PMCID: PMC3090411.
65. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011; 140(6):1729-37. doi: 10.1053/j.gastro.2011.02.012 PMID: 21530739; PubMed Central PMCID: PMC4007055.
66. Indramohan M, Sieve AN, Break TJ, Berg RE. Inflammatory monocyte recruitment is regulated by interleukin-23 during systemic bacterial infection. Infection and immunity. 2012; 80(12):4099-105. doi: 10.1128/IAI.00589-12 PMID: 22966045; PubMed Central PMCID: PMC3497429.
67. Allen IC. Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis. Frontiers in immunology. 2014; 5:169. Epub 2014/05/06. doi: 10.3389/fimmu.2014.00169 PMID: 24795716; PubMed Central PMCID: PMC4001041.
68. Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, Scull MA, et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways. Immunity. 2011; 34(6):854-65. doi: 10.1016/j.immuni.2011.03.026 PMID: 21703540; PubMed Central PMCID: PMC3166771.
69. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature. 2008; 451(7178):573-7. Epub 2008/01/18. doi: 10.1038/nature06501 PMID: 18200010.
70. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, et al. NLRX1 negatively regulates TLR-induced NF-kappaB signaling by targeting TRAF6 and IKK. Immunity. 2011; 34(6):843-53. Epub 2011/06/28. doi: 10.1016/j.immuni.2011.02.022 PMID: 21703539; PubMed Central PMCID: PMC3150212.
71. Lei Y, Wen H, Yu Y, Taxman DJ, Zhang L, Widman DG, et al. The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy. Immunity. 2012; 36(6):933-46. Epub 2012/07/04. doi: 10.1016/j.immuni.2012.03.025 PMID: 22749352; PubMed Central PMCID: PMC3397828.
72. Jaworska J, Coulombe F, Downey J, Tzelepis F, Shalaby K, Tattoli I, et al. NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(20):E2110-9. Epub 2014/05/07. doi: 10.1073/pnas.1322118111 PMID: 24799673; PubMed Central PMCID: PMC4034189.
73. Soares F, Tattoli I, Wortzman ME, Arnoult D, Philpott DJ, Girardin SE. NLRX1 does not inhibit MAVSdependent antiviral signalling. Innate immunity. 2013; 19(4):438-48. Epub 2012/12/06. doi: 10.1177/1753425912467383 PMID: 23212541.
74. Abdul-Sater AA, Said-Sadier N, Lam VM, Singh B, Pettengill MA, Soares F, et al. Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1. The Journal of biological chemistry. 2010; 285(53):41637-45. Epub 2010/10/21. doi: 10.1074/jbc.M110.137885 PMID: 20959452; PubMed Central PMCID: PMC3009891.
75. Tattoli I, Carneiro LA, Jehanno M, Magalhaes JG, Shu Y, Philpott DJ, et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO reports. 2008; 9(3):293-300. Epub 2008/01/26. doi: 10.1038/sj.embor.7401161 PMID: 18219313; PubMed Central PMCID: PMC2267388.
76. Rebsamen M, Vazquez J, Tardivel A, Guarda G, Curran J, Tschopp J. NLRX1/NOD5 deficiency does not affect MAVS signalling. Cell death and differentiation. 2011; 18(8):1387. Epub 2011/05/28. doi: 10.1038/cdd.2011.64 PMID: 21617692; PubMed Central PMCID: PMC3172102.
77. Galvan-Pena S, O'Neill LA. Metabolic reprograming in macrophage polarization. Frontiers in immunology. 2014; 5:420. doi: 10.3389/fimmu.2014.00420 PMID: 25228902; PubMed Central PMCID: PMC4151090.
78. van Doorn NE, Namavar F, Sparrius M, Stoof J, van Rees EP, van Doorn LJ, et al. Helicobacter pyloriassociated gastritis in mice is host and strain specific. Infect Immun. 1999; 67(6):3040-6. Epub 1999/05/25. PMID: 10338517; PubMed Central PMCID: PMC96618.
79. Zhang X, Goncalves R, Mosser DM. The isolation and characterization of murine macrophages. Current protocols in immunology/edited by John E Coligan [et al]. 2008;Chapter 14:Unit 14 1. doi: 10.1002/0471142735.im1401s83 PMID: 19016445; PubMed Central PMCID: PMC2834554.
80. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome biology. 2009; 10(3):R25. doi: 10.1186/gb-2009-10-3-r25 PMID: 19261174; PubMed Central PMCID: PMC2690996.
81. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC bioinformatics. 2011; 12:323. doi: 10.1186/1471-2105-12-323 PMID: 21816040; PubMed Central PMCID: PMC3163565.
82. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nature biotechnology. 2010; 28(5):511-5. doi: 10.1038/nbt.1621 PMID: 20436464; PubMed Central PMCID: PMC3146043.
83. Carbo A, Hontecillas R, Kronsteiner B, Viladomiu M, Pedragosa M, Lu P, et al. Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity. PLoS computational biology. 2013; 9(4):e1003027. doi: 10.1371/journal.pcbi.1003027 PMID: 23592971; PubMed Central PMCID: PMC3617204.
84. Ihaka R, Gentleman R. R: A Language for Data Analysis and Graphics. Journal of Computational and Graphical Statistics. 1996; 5(3):299-314. citeulike-article-id:1454042 doi: 10.2307/1390807
85. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological). 1995:289-300.